PRKAA1 and X-linked adrenoleukodystrophy: Our group documented the novel loss of metabolic gene, AMP-activated protein kinaseα1 (AMPKα1) in cALD patient-derived fibroblasts and lymphocytes [66], postmortem brain tissue [67] and in X-ALD patient iPSC-derived astrocytes [25].